Market Trends of Europe Nano Sensors Industry
This section covers the major market trends shaping the Europe Nano Sensors Market according to our research experts:
Electrochemical biological nano sensors and photometric biological nano sensors find significant demand
- These sensors are used to monitor various biological processes, antigen bodies, and interactions between various biological agents, etc. Nanotubes are used in such sensors and proteins, or any other bodies bind themselves to the nanotubes, indicating a change.
- The various measuring attributes include Antigen/antibody interaction, DNA interaction, and enzymatic interaction, among others. The benefits offered by these sensors include rapid and simultaneous detection of numerous biological parameters, high selectivity, and high sensitivity.
- The use of these biological nanosensors has been highly beneficial in detecting lung cancer, asthma attacks, various kinds of viruses related to influenza, parasites, malaria, among others. With increased commercialization, the demand for these types of nanosensors is also expected to grow in the market.
- Biological nanosensors are also used in military applications for detecting harmful biological agents. Many countries have been increasingly investing in the manufacturing of such sensors due to the increasing threat of biological warfare.
Healthcare industry is expected to fuel the growth of nano sensors over the forecasted period
- Europe is among the top markets when it comes to the healthcare industry, and the growing adoption of technology in the sector is expected further to augment the demand for nanosensors in the region.
- Various monitoring and data collection devices are being incorporated into the healthcare industry with a growing focus on developing solutions. For example, in September 2021, Nanowear, a leading hospital-at-home and remote diagnostic platform, announced that it received its third FDA 510(k) clearance and first software-only clearance as an end-to-end digital platform enabling Nanowear to implement standalone AI and deep learning algorithms that will inform remote diagnoses as Software-as-a-Medical Device (SaMD).
- The growing number of health ailments combined with the aging population is augmenting the demand for innovative solutions. For instance, Germany had the highest prevalence of diabetes in Europe among their adult population, with 15.3% living with diabetes in 2019, Portugal followed with the second-highest share at 14.2%. On the other hand, Ireland was the country with the lowest prevalence of diabetes in Europe at 4.4%.
- Since the outbreak of the Covid-19, the demand for remote monitoring and consultations has grown in the region, along with growth in the number of people using technology for healthcare.